The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project
Open accessAbstract
Key Points: Bleeding in US hemophilia patients has decreased dramatically in parallel with increased use of prophylaxis. Only prophylaxis started before age 4 years preserves normal joint function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although effective, ERT is limited by an approximately 40% noncompliance rate, costs ≥$200,000 annually, and advances arthropathy.172, 173, 174, 175”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [173]
Citations
Cites
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
Manco-Johnson, M. J., Abshire, T. C., Shapiro, A. D., Riske, B., Hacker, M. R., Kilcoyne, R., Ingram, J. D., Manco-Johnson, M. L., Funk, S., Jacobson, L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067659 · Cited by 1,950 · cited 4×
“This age was chosen to align as closely as possible with the Joint Outcomes Study definition, as well as with previous European definitions of primary prophylaxis.(5,13-15) c Primary prophylaxis 4 to 6 years: first documentation of routine FVIII replacement therapy at a UDC visit on or after the fourth birthday but be…”
BackgroundMethodInfluentialSelf-citationTwenty‐five years' experience of prophylactic treatment in severe haemophilia A and B
NILSSON, I. M., BERNTORP, E., LÖFQVIST, T., & PETTERSSON, H. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00546.x · Cited by 961
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
ALEDORT, L. M., HASCHMEYER, R. H., PETTERSSON, H., & THE ORTHOPAEDIC OUTCOME STUDY GROUP (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb00815.x · Cited by 611
SOUCIE, J. M., WANG, C., FORSYTH, A., FUNK, S., DENNY, M., ROACH, K. E., BOONE, D., & THE HEMOPHILIA TREATMENT CENTER NETWORK (2011) · Haemophilia · doi:10.1111/j.1365-2516.2010.02399.x · Cited by 466
Self-citationBlood‐induced joint disease: the pathophysiology of hemophilic arthropathy
VALENTINO, L. A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03962.x · Cited by 294
Fischer, K., van der Bom, J. G., Mauser-Bunschoten, E. P., Roosendaal, G., Prejs, R., de Kleijn, P., Grobbee, D. E., & van den Berg, M. (2002) · Blood · doi:10.1182/blood.v99.7.2337 · Cited by 258
VALENTINO, L. A., MAMONOV, V., HELLMANN, A., QUON, D. V., CHYBICKA, A., SCHROTH, P., PATRONE, L., & WONG, W. ‐. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04611.x · Cited by 253
Manco-Johnson, M. J., Kempton, C. L., Reding, M. T., Lissitchkov, T., Goranov, S., Gercheva, L., Rusen, L., Ghinea, M., Uscatescu, V., Rescia, V., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12202 · Cited by 197
Self-citationLee, C. A., Kessler, C. M., Varon, D., Martinowitz, U. P., Heim, M., Kreuz, W., Escuriola‐Ettingshausen, C., Funk, M. J., SCHMIDT, H., & Kornhuber, B. (1998) · Haemophilia · doi:10.1046/j.1365-2516.1998.440413.x · Cited by 154
Results of secondary prophylaxis in children with severe hemophilia
Manco‐Johnson, M. J., Nuss, R., Geraghty, S. J., Funk, S. M., & Kilcoyne, R. F. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830470209 · Cited by 146
Self-citation
Cited by
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
Rangarajan, S., Walsh, L., Lester, W., Perry, D., Madan, B., Laffan, M., Yu, H., Vettermann, C., Pierce, G. F., Wong, W. Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708483 · Cited by 694
Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
Ozelo, M. C., Mahlangu, J., Pasi, K. J., Giermasz, A., Leavitt, A. D., Laffan, M., Symington, E., Quon, D. V., Wang, J.-D., Peerlinck, K., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2113708 · Cited by 417
Berntorp, E., Fischer, K., Hart, D. P., Mancuso, M. E., Stephensen, D., Shapiro, A. D., & Blanchette, V. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00278-x · Cited by 328
Hemophilic arthropathy: Current knowledge and future perspectives
Gualtierotti, R., Solimeno, L. P., & Peyvandi, F. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15444 · Cited by 307
Metadata
- Authors
- Manco-Johnson, M. J., Soucie, J. M., & Gill, J. C.
- Affiliations
- University of Colorado Anschutz (US)
- Centers for Disease Control and Prevention (US)
- Medical College of Wisconsin (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-04-27
- Volume
- 129
- Issue
- 17
- Pages
- 2368-2374
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC5409445
- OpenAlex
- W2586474705
- Cited by
- 166
- References
- 18
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 17 · 2023: 19 · 2022: 18 · 2021: 27 · 2020: 26 · 2019: 11 · 2018: 21 · 2017: 4
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CC999999)
- Centers for Disease Control and Prevention (U01DD000198)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Keywords
- hemophilia, prophylaxis, bleeding rate, joint outcomes, national registry, treatment trends, health care networks
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Child, Child, Preschool, Cross-Sectional Studies, Factor VIII, Hemarthrosis, Hemophilia A, Hemorrhage, Humans, Joints, Male, Middle Aged, Office Visits, Primary Prevention, Prospective Studies, Registries, United States, Range of Motion, Articular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project. https://app.cochat.ai/papers/10.1182/blood-2016-02-683169
- The paper
- Manco-Johnson, M. J., Soucie, J. M., & Gill, J. C. (2017). Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project. Blood. https://doi.org/10.1182/blood-2016-02-683169
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.